Cite
MLA Citation
Shiao-Pei Weathers et al.. “Results of a phase I trial to assess the safety of macitentan in combination with temozolomide for the treatment of recurrent glioblastoma.” Neuro-oncology advances, vol. 3, no. 1, 2021, p. . http://access.bl.uk/ark:/81055/vdc_100146089938.0x000002